NAV

Methylthioinosine

Identification

Generic Name
Methylthioinosine
DrugBank Accession Number
DB02896
Background

An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position.

Type
Small Molecule
Groups
Experimental
Structure
3D
Similar Structures
Weight
Average: 298.318
Monoisotopic: 298.073575646
Chemical Formula
C11H14N4O4S
Synonyms
  • 6-(Methylthio)purine ribonucleoside
  • 6-methyl MP riboside
  • 6-methyl MP-riboside
  • 6-methyl-9-ribofuranosylpurine-6-thiol
  • 6-methylmercaptopurine ribonucleoside
  • 6-methylmercaptopurine riboside
  • 6-Methylmercaptopurine-riboside
  • 6-methylthioinosine
  • 6-methylthiopurine riboside
  • 6-MMPR
  • 6-S-methyl-6-thioinosine
  • Me6MPR
  • methylmercaptopurine riboside
  • MMPR
External IDs
  • NCI-C04784
  • NSC-40774
  • NSC-49555
  • SQ-21977
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UPurine nucleoside phosphorylase DeoD-typeNot AvailableEscherichia coli (strain K12)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

IPR-RAT LD50: 65 mg/kg

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as purine nucleosides. These are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety.
Kingdom
Organic compounds
Super Class
Nucleosides, nucleotides, and analogues
Class
Purine nucleosides
Sub Class
Not Available
Direct Parent
Purine nucleosides
Alternative Parents
Glycosylamines / 6-thiopurines / Pentoses / Alkylarylthioethers / Pyrimidines and pyrimidine derivatives / N-substituted imidazoles / Tetrahydrofurans / Heteroaromatic compounds / Secondary alcohols / Sulfenyl compounds
show 6 more
Substituents
6-thiopurine / Alcohol / Alkylarylthioether / Aromatic heteropolycyclic compound / Aryl thioether / Azacycle / Azole / Glycosyl compound / Heteroaromatic compound / Hydrocarbon derivative
show 22 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
thiopurine, purine ribonucleoside (CHEBI:44081)
Affected organisms
Not Available

Chemical Identifiers

UNII
Y5G39SHR0V
CAS number
342-69-8
InChI Key
ZDRFDHHANOYUTE-IOSLPCCCSA-N
InChI
InChI=1S/C11H14N4O4S/c1-20-10-6-9(12-3-13-10)15(4-14-6)11-8(18)7(17)5(2-16)19-11/h3-5,7-8,11,16-18H,2H2,1H3/t5-,7-,8-,11-/m1/s1
IUPAC Name
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(methylsulfanyl)-9H-purin-9-yl]oxolane-3,4-diol
SMILES
CSC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O

References

General References
Not Available
PubChem Compound
9570
PubChem Substance
46505005
ChemSpider
9195
BindingDB
50412071
ChEBI
44081
ChEMBL
CHEMBL388931
ZINC
ZINC000000519128
PDBe Ligand
MTP
PDB Entries
1pr4 / 2aa0 / 2ab8 / 6c9p
MSDS
Download (51.5 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)164 °CPhysProp
logP0.09SANGSTER (1994)
Predicted Properties
PropertyValueSource
Water Solubility8.21 mg/mLALOGPS
logP-0.4ALOGPS
logP-0.63Chemaxon
logS-1.6ALOGPS
pKa (Strongest Acidic)12.45Chemaxon
pKa (Strongest Basic)3.31Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count7Chemaxon
Hydrogen Donor Count3Chemaxon
Polar Surface Area113.52 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity71.25 m3·mol-1Chemaxon
Polarizability28.85 Å3Chemaxon
Number of Rings3Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption-0.5
Blood Brain Barrier-0.6699
Caco-2 permeable-0.7396
P-glycoprotein substrateNon-substrate0.7196
P-glycoprotein inhibitor INon-inhibitor0.9212
P-glycoprotein inhibitor IINon-inhibitor0.9449
Renal organic cation transporterNon-inhibitor0.9198
CYP450 2C9 substrateNon-substrate0.7261
CYP450 2D6 substrateNon-substrate0.8166
CYP450 3A4 substrateNon-substrate0.5213
CYP450 1A2 substrateNon-inhibitor0.9183
CYP450 2C9 inhibitorNon-inhibitor0.9273
CYP450 2D6 inhibitorNon-inhibitor0.9508
CYP450 2C19 inhibitorNon-inhibitor0.9252
CYP450 3A4 inhibitorNon-inhibitor0.9866
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9057
Ames testAMES toxic0.8296
CarcinogenicityNon-carcinogens0.8857
BiodegradationNot ready biodegradable0.8971
Rat acute toxicity2.4718 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9949
hERG inhibition (predictor II)Non-inhibitor0.8175
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-00yl-9480000000-9f941f3b696fef4bc712
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0920000000-425b1c59b5df1a8ebba1
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-2490000000-263bdc2b4e0e4aae48bd
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0900000000-f8ee6273703e5926df4a
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-0900000000-e9a6dc217e65143eba61
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-2900000000-1aa738dd2ea8a6959db9
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00kb-6900000000-acc923940b456b371803
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0920000000-425b1c59b5df1a8ebba1
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-2490000000-263bdc2b4e0e4aae48bd
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-0900000000-f8ee6273703e5926df4a
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-014i-2900000000-1aa738dd2ea8a6959db9
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-0900000000-e9a6dc217e65143eba61
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-00kb-6900000000-acc923940b456b371803
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-178.7807611
predicted
DarkChem Lite v0.1.0
[M-H]-157.76994
predicted
DeepCCS 1.0 (2019)
[M-H]-178.7807611
predicted
DarkChem Lite v0.1.0
[M-H]-157.76994
predicted
DeepCCS 1.0 (2019)
[M+H]+179.4393611
predicted
DarkChem Lite v0.1.0
[M+H]+160.16551
predicted
DeepCCS 1.0 (2019)
[M+H]+179.4393611
predicted
DarkChem Lite v0.1.0
[M+H]+160.16551
predicted
DeepCCS 1.0 (2019)
[M+Na]+178.6791611
predicted
DarkChem Lite v0.1.0
[M+Na]+167.40265
predicted
DeepCCS 1.0 (2019)
[M+Na]+178.6791611
predicted
DarkChem Lite v0.1.0
[M+Na]+167.40265
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Details1. Purine nucleoside phosphorylase DeoD-type
Kind
Protein
Organism
Escherichia coli (strain K12)
Pharmacological action
Unknown
General Function
Purine-nucleoside phosphorylase activity
Specific Function
Cleavage of guanosine or inosine to respective bases and sugar-1-phosphate molecules.
Gene Name
deoD
Uniprot ID
P0ABP8
Uniprot Name
Purine nucleoside phosphorylase DeoD-type
Molecular Weight
25949.68 Da
References
  1. Bennett EM, Li C, Allan PW, Parker WB, Ealick SE: Structural basis for substrate specificity of Escherichia coli purine nucleoside phosphorylase. J Biol Chem. 2003 Nov 21;278(47):47110-8. Epub 2003 Aug 21. [Article]

Drug created at June 13, 2005 13:24 / Updated at January 07, 2021 03:10